Hepatopulmonary syndrome epidemiology and demographics
Hepatopulmonary syndrome Microchapters |
Differentiating Hepatopulmonary syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Hepatopulmonary syndrome epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Hepatopulmonary syndrome epidemiology and demographics |
FDA on Hepatopulmonary syndrome epidemiology and demographics |
CDC on Hepatopulmonary syndrome epidemiology and demographics |
Hepatopulmonary syndrome epidemiology and demographics in the news |
Blogs on Hepatopulmonary syndrome epidemiology and demographics |
Risk calculators and risk factors for Hepatopulmonary syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]
Overview
Epidemiology and Demographics
Incidence
- The incidence/prevalence of hepatopulmonary syndrome is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of hepatopulmonary syndrome was estimated to be [number range] cases per 100,000 individuals worldwide.
Prevalence
- The incidence/prevalence of hepatopulmonary syndrome is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of hepatopulmonary syndrome was estimated to be [number range] cases per 100,000 individuals worldwide.
- The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
Case-fatality rate/Mortality rate
- In [year], the incidence of hepatopulmonary syndrome is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of hepatopulmonary syndrome is approximately [number range].
Age
- Patients of all age groups may develop hepatopulmonary syndrome.
- The incidence of hepatopulmonary syndrome increases with age; the median age at diagnosis is [#] years.
- hepatopulmonary syndrome commonly affects individuals younger than/older than [number of years] years of age.
- [Chronic disease name] is usually first diagnosed among [age group].
- [Acute disease name] commonly affects [age group].
Race
- There is no racial predilection to hepatopulmonary syndrome.
- hepatopulmonary syndrome usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop hepatopulmonary syndrome.
Gender
- hepatopulmonary syndrome affects men and women equally.
- [Gender 1] are more commonly affected by hepatopulmonary syndrome than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
Region
- The majority of hepatopulmonary syndrome cases are reported in [geographical region].
- hepatopulmonary syndrome is a common/rare disease that tends to affect [patient population 1] and [patient population 2].